Xue Jun Su
Direktor/Vorstandsmitglied bei SSY GROUP LIMITED
Vermögen: 15 Mio $ am 30.04.2024
Profil
Xue Jun Su is currently an Executive Director at SSY Group Ltd.
and New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
Previously, he worked as Deputy Chairman at Shijiazhuang No.
4 Pharmaceutical Co., Ltd.
and as a Factory Manager at Shijiazhuang No 1 Pharmaceutical Factory.
Mr. Su obtained an undergraduate degree from Hebei Normal University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SSY GROUP LIMITED
0,82% | 30.06.2023 | 24 416 000 ( 0,82% ) | 15 Mio $ | 30.04.2024 |
Aktive Positionen von Xue Jun Su
| Unternehmen | Position | Beginn |
|---|---|---|
| SSY GROUP LIMITED | Direktor/Vorstandsmitglied | 15.12.2014 |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Direktor/Vorstandsmitglied | 07.01.2007 |
Ehemalige bekannte Positionen von Xue Jun Su
| Unternehmen | Position | Ende |
|---|---|---|
| Shijiazhuang No 1 Pharmaceutical Factory | Corporate Officer/Principal | - |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Vorsitzender | - |
Ausbildung von Xue Jun Su
| Hebei Normal University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
| Shijiazhuang No 1 Pharmaceutical Factory |
